HCAR2 and melanoma: We report here for the first time that expression of Niacin receptors HCAR2 and HCAR3 is almost completely lost in melanoma patients and the PCA (Principal Component Analysis) carried out on the combined expression of Niacin receptors revealed their ability to separate melanoma patients from healthy controls, indicating Niacin receptors as potentially relevant melanoma markers.